geraniol has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fatima, K; Luqman, S; Meena, A; Wani, ZA | 1 |
| Burke, YD; Crowell, PL; Roach, SL; Sen, SE; Stark, MJ | 1 |
2 other study(ies) available for geraniol and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Geraniol exerts its antiproliferative action by modulating molecular targets in lung and skin carcinoma cells.
Topics: A549 Cells; Acyclic Monoterpenes; Carcinoma; Cell Line, Tumor; Humans; Lung Neoplasms; Molecular Docking Simulation; Skin Neoplasms | 2021 |
Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol.
Topics: Acyclic Monoterpenes; Animals; Antineoplastic Agents; Carcinoma; Cricetinae; Drug Screening Assays, Antitumor; Farnesol; Humans; Mesocricetus; Monoterpenes; Pancreatic Neoplasms; Terpenes; Tumor Cells, Cultured | 1997 |